Clearline Capital’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.48M Sell
136,125
-144,928
-52% -$7.97M 0.28% 51
2025
Q1
$19.9M Sell
281,053
-96,429
-26% -$6.82M 1.2% 13
2024
Q4
$24.8M Buy
377,482
+57,710
+18% +$3.79M 3.28% 8
2024
Q3
$22.5M Buy
+319,772
New +$22.5M 0.95% 12